Pasar al contenido principal

EVALUACION DE LA COMPLEJIDAD FUNCIONAL DE LOS GPCRS MEDIANTE METODOS COMPUTACIONALES: EL DOLOR CRONICO DESDE UNA PERSPECTIVA DE FARMACOLOGIA MOLECULAR

PID2020-119136RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Allosteric binding cooperativity in a kinetic context

  • Díaz Sanzo, Óscar|||0000-0002-8374-1693
  • Martín, Victor
  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon, Antoni|||0000-0001-8268-4503
  • Giraldo, Jesús|||0000-0001-7082-4695
Allosteric modulators are of prime interest in drug discovery. These drugs regulate the binding and function of endogenous ligands, with some advantages over orthosteric ligands. A typical pharmacological parameter in allosteric modulation is binding cooperativity. This property can yield unexpected but illuminating results when decomposed into its kinetic parameters. Using two reference models (the allosteric ternary complex receptor model and a heterodimer receptor model), a relationship has been derived for the cooperativity rate constant parameters. This relationship allows many combinations of the cooperativity kinetic parameters for a single binding cooperativity value obtained under equilibrium conditions. This assessment may help understand striking experimental results involving allosteric modulation and suggest further investigations in the field.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A 19F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling

  • Giraldo, Jesús|||0000-0001-7082-4695
  • Madsen, Jesper Jonasson|||0000-0003-1411-9080
  • Wang, Xudong
  • Wang, Lei
  • Zhang, Cheng
  • Ye, Libin
G protein-coupled receptors (GPCRs) exhibit a wide range of pharmacological efficacies, yet the molecular mechanisms responsible for the differential efficacies in response to various ligands remain poorly understood. This lack of understanding has hindered the development of a solid foundation for establishing a mathematical model for signaling efficacy. However, recent progress has been made in delineating and quantifying receptor conformational states and associating function with these conformations. This progress has allowed us to construct a mathematical model for GPCR signaling efficacy that goes beyond the traditional ON/OFF binary switch model. In this study, we present a quantitative conformation-based mathematical model for GPCR signaling efficacy using the adenosine A receptor (AR) as a model system, under the guide of F quantitative nuclear magnetic resonance experiments. This model encompasses two signaling states, a fully activated state and a partially activated state, defined as being able to regulate the cognate Ga nucleotide exchange with respective G protein recognition capacity. By quantifying the population distribution of each state, we can now in turn examine GPCR signaling efficacy. This advance provides a foundation for assessing GPCR signaling efficacy using a conformation-based mathematical model in response to ligand binding.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Structural Determinants of Buprenorphine Partial Agonism at the μ-Opioid Receptor

  • Severo Gomes, Antoniel Augusto|||0000-0002-1278-7838
  • Giraldo, Jesús|||0000-0001-7082-4695
The μ-opioid receptor (μOR) is a class A G Protein-Coupled Receptor (GPCR) targeted by natural and synthetic ligands to provide analgesia to patients with pain of various etiologies. Available opioid medications present several unwanted side effects, stressing the need for safer pain therapies. Despite the attractive proposal that biasing μOR signaling toward G protein pathways would lead to fewer side effects, recent studies indicate that low-efficacy opioid drugs, such as buprenorphine, may represent a safer alternative. In the present work, we combine molecular docking, microsecond-time scale molecular dynamics (MD) simulations, and metadynamics to investigate the conformational dynamics of the μOR bound to morphine or buprenorphine. Our objective was to determine structural aspects associated with the unique pharmacological effects caused by the latter, taking morphine as a reference. MD simulations identified a salt bridge with D149 as crucial for stabilizing both ligands into the μOR orthosteric site, with this interaction being weaker in buprenorphine. The morphinan-scaffold of both ligands shared contacts with transmembrane (TM) helix residues of the receptor, including TM3, TM5, TM6, and TM7. Conversely, while morphine showed stronger interactions with a few TM3 residues, additional chemical groups of buprenorphine showed stronger interactions with TM2, extracellular loop 2 (ECL2), and TM7 residues. We also observed distinct TM arrangements induced by these ligands, with buprenorphine causing an extracellular outward movement of TM7 and morphine provoking intracellular inward movements of TM5 and TM7 of the receptor. In addition, we found that buprenorphine tends to explore deeper regions in the μOR orthosteric site, further supported by funnel-metadynamics, resulting in diverse side chain orientations of W295. Metadynamics also unveiled distinct intermediate states for morphine and buprenorphine, with the latter accessing a secondary binding site associated with partial μOR agonists. Our results indicate that the weakened salt bridge of buprenorphine with D149, along with the strong TM7 interaction through its cyclopropyl group, may explain its low efficacy and consequent partial μOR agonism. Furthermore, ECL2 interactions may contribute to explaining the biased agonism of buprenorphine, a common feature shared with other opioid modulators with similar functional effects. Our study sheds light on the complex pharmacology of buprenorphine, identifying structural aspects associated with its partial and biased μOR agonism. These results can provide valuable information for the design of new effective and safer opioid drugs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A mathematical formalism to quantify drug-target residence time

  • Ortiz, Antonio J.
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon, Antoni|||0000-0001-8268-4503
  • Giraldo, Jesús|||0000-0001-7082-4695
Despite drug-target residence time (RT) is a key topic in binding kinetics, little information exists on its theoretical quantification. The two most frequent mathematical expressions found in the literature correspond to two particular and simple pharmacological cases: the binary ligand-receptor complex and the induction-fit model. In this article, we propose a mathematical formalism to obtain an expression of RT that can be of general applicability. RT is calculated from the system of ordinary differential equations (ODE) obtained by applying the Law of Mass Action to the selected chemical process. Then, a subsystem is constructed by defining which chemical species are of interest and omitting their global formation processes. RT maintains its accepted definition of 1/koff, where koff is here defined as the absolute value of the smallest-modulus eigenvalue of the subsystem. The proposed procedure is successfully used to derive RT for a wide variety of pharmacological cases. In particular, the theoretical expressions of RT obtained for binary ligand-receptor binding and induction-fit coincide with those previously found in the literature. An extension of the RT pharmacological framework is proposed by including the concept of relaxation time (RXT), which involves pharmacological conditions associated with receptor activation rather than receptor binding. To conclude, the herein presented formalism for RT and RXT provides a mathematical framework that can be of general applicability in many pharmacological systems. It is expected that the procedure may be helpful in different pharmacological areas such as binding kinetics, PK/PD and enzymology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Subtype-Selective Binding Sites in the Opioid Receptor Family

  • Severo Gomes, Antoniel Augusto|||0000-0002-1278-7838
  • Guillot, Benoît|||0000-0002-9992-4427
  • Jelsch, Christian|||0000-0002-2655-0313
  • Giraldo, Jesús|||0000-0001-7082-4695
Selectivity is essential in drug discovery for finding or developing more effective opioid modulators. Structure-based approaches and binding kinetics effectively identify potential druggable regions and determine ligand candidates for improved therapies. In this study, we combined molecular dynamics simulations and funnel-metadynamics with charge density analyses to identify unique structural aspects of the main opioid receptors (ORs), including the mu (μOR), delta (δOR), and kappa (κOR). We found distinct conformational dynamics between the receptors, with the κOR extracellular vestibule tending to form a lid that covers its orthosteric site. Furthermore, we investigated how morphinan-scaffold ligands with distinct pharmacological effects bind to OR orthosteric sites and extracellular vestibules, identifying intermediate ligand states. The lowest-energy states of each complex reproduced the morphinan-like orientation revealed by experimental structures and experimental free energy of binding. Moreover, we determined the role of orthosteric subpockets and extracellular loops (ECLs) in stabilizing ligand-bound states, shedding light on ligand selectivity. Our results provide a detailed description, from an energetic perspective, of the conformational dynamics and structure-based selectivity determination within the OR family. These regions can be rationally targeted for designing and developing functionally selective opioid modulators with improved pharmacological effects in pain treatment or other OR-related diseases.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Drug–target residence time: Analyzing cooperativity effects in G protein-coupled receptors by mathematical modeling and molecular dynamics simulations

  • Ortiz García, José Antonio
  • Gomes, Antoniel A.S.|||0000-0002-1278-7838
  • Renault de Barros, Pedro Víctor
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon Grabolosa, Antoni|||0000-0001-8268-4503
  • Giraldo Arjonilla, Jesús
Drug–target residence time (t) is reviewed from two perspectives: mathematics and molecular dynamics. The first focuses on the quantification of t using a mathematical formalism applicable to different pharmacological mechanistic conditions. This formalism is based on the concept of the smallest-modulus eigenvalue of a subsystem of interest, in which the global formation process has been eliminated. The second includes relevant studies of recent years to provide a structural explanation of t predictions. Special attention is paid to physically supported artificial intelligence methods. The main objective of this minireview is to promote a combined approach in which mathematics and physics work synergistically to describe the complexity associated with t in G protein-coupled receptors., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model

  • Ortiz García, José Antonio
  • Ortega, Víctor Martín
  • Romero Sánchez, David
  • Guillamon Grabolosa, Antoni|||0000-0001-8268-4503
  • Giraldo Arjonilla, Jesús
GPCRs heteromerize both in CNS and non-CNS regions. The cell uses receptor heteromerization to modulate receptor functionality and to provide fine tuning of receptor signaling. In order for pharmacologists to explore these mechanisms for therapeutic purposes, quantitative receptor models are needed. We have developed a timedependent model of the binding kinetics and functionality of a preformed heterodimeric receptor involving two drugs. Two cases were considered: both or only one of the drugs are in excess with respect to the total concentration of the receptor. The latter case can be applied to those situations in which a drug causes unwanted side effects that need to be reduced by decreasing its concentration. The required efficacy can be maintained by the allosteric effects mutually exerted by the two drugs in the two-drug combination system. We discuss this concept assuming that the drug causing unwanted side effects is an opioid and that analgesia is the therapeutic effect. As additional points, allosteric modulation by endogenous compounds and synthetic bivalent ligands was included in the study. Receptor heteromerization offers a mechanistic understanding and quantification of the pharmacological effects elicited by combinations of two drugs at different doses and with different efficacies and cooperativity effects, thus providing a conceptual framework for drug combination therapy., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 848068. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. This work is partially supported by the grants PID2020-119136RB-I00, PID-2021-122954NB-I00, PID2022-137708NB-I00 and the Severo Ochoa and María de Maeztu Programs for Centers and Units of Excellence in R&D (CEX2020-001084-M) funded by MCIN/AEI/10.13039/501100011033 and by ERDF “A way of making Europe”, and by the AGAUR grant 2021-SGR-01039. AJO is funded by FPI fellowship (PRE2021-100772) associated to PID2020-119136RB-I00 grant., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

A mathematical formalism to quantify drug-target residence time

  • Ortiz García, José Antonio
  • Romero Sánchez, David
  • Guillamon Grabolosa, Antoni|||0000-0001-8268-4503
  • Giraldo Arjonilla, Jesús
Despite drug-target residence time (RT) is a key topic in binding kinetics, little information exists on its theoretical quantification. The two most frequent mathematical expressions found in the literature correspond to two particular and simple pharmacological cases: the binary ligand-receptor complex and the induction-fit model. In this article, we propose a mathematical formalism to obtain an expression of RT that can be of general applicability. RT is calculated from the system of ordinary differential equations (ODE) obtained by applying the Law of Mass Action to the selected chemical process. Then, a subsystem is constructed by defining which chemical species are of interest and omitting their global formation processes. RT maintains its accepted definition of 1/koff, where koff is here defined as the absolute value of the smallest-modulus eigenvalue of the subsystem. The proposed procedure is successfully used to derive RT for a wide variety of pharmacological cases. In particular, the theoretical expressions of RT obtained for binary ligand-receptor binding and induction-fit coincide with those previously found in the literature. An extension of the RT pharmacological framework is proposed by including the concept of relaxation time (RXT), which involves pharmacological conditions associated with receptor activation rather than receptor binding. To conclude, the herein presented formalism for RT and RXT provides a mathematical framework that can be of general applicability in many pharmacological systems. It is expected that the procedure may be helpful in different pharmacological areas such as binding kinetics, PK/PD and enzymology., This project has received funding from the European Union’s Horizon2020 research and innovation programme under grant agreement No 848068. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. This work is partially supported by the grants PID2020-119136RB-I00, PID-2021-122954NB-I00 and the Severo Ochoa and María de Maeztu Programs for Centers and Units of Excellence in R&D (CEX2020-001084-M) funded by MCIN/AEI/ 10.13039/ 501100011033 and by ERDF “A way of making Europe”, and by the AGAUR grant 2021-SGR-01039. AJO is funded by FPI fellowship (PRE2021-100772) associated to PID2020-119136RB-I00 grant. We thank Dr Adriaan IJzerman from Leiden University for providing us the experimental data of 2 out of 5 independent experiments, which were used to depict the exponential decays in Section 3.3., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model

  • Ortiz García, José Antonio
  • Ortega, Víctor Martín
  • Romero Sánchez, David
  • Guillamon Grabolosa, Antoni
  • Giraldo Arjonilla, Jesús
GPCRs heteromerize both in CNS and non-CNS regions. The cell uses receptor heteromerization to modulate receptor functionality and to provide fine tuning of receptor signaling. In order for pharmacologists to explore these mechanisms for therapeutic purposes, quantitative receptor models are needed. We have developed a timedependent model of the binding kinetics and functionality of a preformed heterodimeric receptor involving two drugs. Two cases were considered: both or only one of the drugs are in excess with respect to the total concentration of the receptor. The latter case can be applied to those situations in which a drug causes unwanted side effects that need to be reduced by decreasing its concentration. The required efficacy can be maintained by the allosteric effects mutually exerted by the two drugs in the two-drug combination system. We discuss this concept assuming that the drug causing unwanted side effects is an opioid and that analgesia is the therapeutic effect. As additional points, allosteric modulation by endogenous compounds and synthetic bivalent ligands was included in the study. Receptor heteromerization offers a mechanistic understanding and quantification of the pharmacological effects elicited by combinations of two drugs at different doses and with different efficacies and cooperativity effects, thus providing a conceptual framework for drug combination therapy., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 848068. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. This work is partially supported by the grants PID2020-119136RB-I00, PID-2021-122954NB-I00, PID2022-137708NB-I00 and the Severo Ochoa and María de Maeztu Programs for Centers and Units of Excellence in R&D (CEX2020-001084-M) funded by MCIN/AEI/10.13039/501100011033 and by ERDF “A way of making Europe”, and by the AGAUR grant 2021-SGR-01039. AJO is funded by FPI fellowship (PRE2021-100772) associated to PID2020-119136RB-I00 grant., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Drug–target residence time: Analyzing cooperativity effects in G protein-coupled receptors by mathematical modeling and molecular dynamics simulations

  • Ortiz García, José Antonio
  • Gomes, Antoniel A.S.
  • Renault de Barros, Pedro Víctor
  • Romero i Sànchez, David
  • Guillamon Grabolosa, Antoni
  • Giraldo Arjonilla, Jesús
Drug–target residence time (t) is reviewed from two perspectives: mathematics and molecular dynamics. The first focuses on the quantification of t using a mathematical formalism applicable to different pharmacological mechanistic conditions. This formalism is based on the concept of the smallest-modulus eigenvalue of a subsystem of interest, in which the global formation process has been eliminated. The second includes relevant studies of recent years to provide a structural explanation of t predictions. Special attention is paid to physically supported artificial intelligence methods. The main objective of this minireview is to promote a combined approach in which mathematics and physics work synergistically to describe the complexity associated with t in G protein-coupled receptors., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A mathematical formalism to quantify drug-target residence time

  • Ortiz García, José Antonio
  • Romero Sánchez, David
  • Guillamon Grabolosa, Antoni
  • Giraldo Arjonilla, Jesús
Despite drug-target residence time (RT) is a key topic in binding kinetics, little information exists on its theoretical quantification. The two most frequent mathematical expressions found in the literature correspond to two particular and simple pharmacological cases: the binary ligand-receptor complex and the induction-fit model. In this article, we propose a mathematical formalism to obtain an expression of RT that can be of general applicability. RT is calculated from the system of ordinary differential equations (ODE) obtained by applying the Law of Mass Action to the selected chemical process. Then, a subsystem is constructed by defining which chemical species are of interest and omitting their global formation processes. RT maintains its accepted definition of 1/koff, where koff is here defined as the absolute value of the smallest-modulus eigenvalue of the subsystem. The proposed procedure is successfully used to derive RT for a wide variety of pharmacological cases. In particular, the theoretical expressions of RT obtained for binary ligand-receptor binding and induction-fit coincide with those previously found in the literature. An extension of the RT pharmacological framework is proposed by including the concept of relaxation time (RXT), which involves pharmacological conditions associated with receptor activation rather than receptor binding. To conclude, the herein presented formalism for RT and RXT provides a mathematical framework that can be of general applicability in many pharmacological systems. It is expected that the procedure may be helpful in different pharmacological areas such as binding kinetics, PK/PD and enzymology., This project has received funding from the European Union’s Horizon2020 research and innovation programme under grant agreement No 848068. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. This work is partially supported by the grants PID2020-119136RB-I00, PID-2021-122954NB-I00 and the Severo Ochoa and María de Maeztu Programs for Centers and Units of Excellence in R&D (CEX2020-001084-M) funded by MCIN/AEI/ 10.13039/ 501100011033 and by ERDF “A way of making Europe”, and by the AGAUR grant 2021-SGR-01039. AJO is funded by FPI fellowship (PRE2021-100772) associated to PID2020-119136RB-I00 grant. We thank Dr Adriaan IJzerman from Leiden University for providing us the experimental data of 2 out of 5 independent experiments, which were used to depict the exponential decays in Section 3.3., Peer Reviewed, Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico Single-Point Mutation

  • Díaz Sanzo, Óscar|||0000-0002-8374-1693
  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Giraldo, Jesús|||0000-0001-7082-4695
Cannabinoid receptor 1 (CB1) is a promising drug target involved in many physiological processes. Using atomistic molecular dynamics (MD) simulations, we examined the structural effect of F237L mutation on CB1, a mutation that has qualitatively similar effects to allosteric ligand ORG27569 binding. This mutation showed a global effect on CB1 conformations. Among the observed effects, TM6 outward movement and the conformational change of the NPxxY motif upon receptor activation by CB1 agonist CP55940 were hindered compared to wt CB1. Within the orthosteric binding site, CP55940 interactions with CB1 were altered. Our results revealed that allosteric perturbations introduced by the mutation had a global impact on receptor conformations, suggesting that the mutation site is a key region for allosteric modulation in CB1.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model

  • Ortiz, Antonio J.
  • Martín, Víctor
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon, Antoni|||0000-0001-8268-4503
  • Giraldo, Jesús|||0000-0001-7082-4695
GPCRs heteromerize both in CNS and non-CNS regions. The cell uses receptor heteromerization to modulate receptor functionality and to provide fine tuning of receptor signaling. In order for pharmacologists to explore these mechanisms for therapeutic purposes, quantitative receptor models are needed. We have developed a time-dependent model of the binding kinetics and functionality of a preformed heterodimeric receptor involving two drugs. Two cases were considered: both or only one of the drugs are in excess with respect to the total concentration of the receptor. The latter case can be applied to those situations in which a drug causes unwanted side effects that need to be reduced by decreasing its concentration. The required efficacy can be maintained by the allosteric effects mutually exerted by the two drugs in the two-drug combination system. We discuss this concept assuming that the drug causing unwanted side effects is an opioid and that analgesia is the therapeutic effect. As additional points, allosteric modulation by endogenous compounds and synthetic bivalent ligands was included in the study. Receptor heteromerization offers a mechanistic understanding and quantification of the pharmacological effects elicited by combinations of two drugs at different doses and with different efficacies and cooperativity effects, thus providing a conceptual framework for drug combination therapy.